Search

For the last two decades, experimental information on nuclear level densities for about 60 different nuclei has been obtained on the basis of the Oslo method. While each of these measurements has been typically compared to one or a few level density models, a global study including all the measurements has been missing. The present study provides a systematic comparison between Oslo data and six global level density models for 42 nuclei for which $s$-wave resonance spacings are also available. We apply a coherent normalization procedure to the Oslo data for each of the six different models, all being treated on the same footing. Our quantitative analysis shows that the constant-temperature model presents the best global description of the Oslo data, closely followed by the mean-field plus combinatorial model and Hartree-Fock plus statistical model. Their accuracies are quite similar, so that it remains difficult to clearly favour one of these models. When considering energies above the threshold where the experimental level scheme is complete, all the six models are shown to lead to rather similar accuracies with respect to Oslo data. The recently proposed shape method can, in principle, improve the situation since it provides an absolute estimate of the excitation-energy dependence of the measured level densities. We show for the specific case of $^{112}$Cd that the shape method could exclude the Hartree-Fock plus statistical model. Such an analysis remains to be performed for the bulk of data for which the shape method can be applied to the Oslo measurements before drawing conclusions on the general quality of a given nuclear level density model., Comment: 11 pages, 7 figures, published in PRC

Heavy-ion therapy, particularly using scanned (active) beam delivery, provides a precise and highly conformal dose distribution, with maximum dose deposition for each pencil beam at its endpoint (Bragg peak), and low entrance and exit dose. To take full advantage of this precision, robust range verification methods are required; these methods ensure that the Bragg peak is positioned correctly in the patient and the dose is delivered as prescribed. Relative range verification allows intra-fraction monitoring of Bragg peak spacing to ensure full coverage with each fraction, as well as inter-fraction monitoring to ensure all fractions are delivered consistently. To validate the proposed filtered Interaction Vertex Imaging method for relative range verification, a ${}^{16}$O beam was used to deliver 12 Bragg peak positions in a 40 mm poly-(methyl methacrylate) phantom. Secondary particles produced in the phantom were monitored using position-sensitive silicon detectors. Events recorded on these detectors, along with a measurement of the treatment beam axis, were used to reconstruct the sites of origin of these secondary particles in the phantom. The distal edge of the depth distribution of these reconstructed points was determined with logistic fits, and the translation in depth required to minimize the $\chi^2$ statistic between these fits was used to compute the range shift between any two Bragg peak positions. In all cases, the range shift was determined with sub-millimeter precision, to a standard deviation of the mean of 220(10) $\mu$m. This result validates filtered Interaction Vertex Imaging as a reliable relative range verification method, which should be capable of monitoring each energy step in each fraction of a scanned heavy-ion treatment plan., Comment: 29 pages, 12 figures. Accepted version: Clarified language throughout, added summary of recent related clinical work, added detail on detection & reconstruction systems, added explicit evaluation of detection system, replaced comparison to simulation with comparison to prior studies, extended discussion of clinical applicability. Results & conclusions on range verification performance unchanged

In this work, we propose a novel technique for in-vivo proton therapy range verification. This technique makes use of a small hadron tumour marker, $^{92}$Mo, implanted at a short known distance from the clinical treatment volume. Signals emitted from the marker during treatment can provide a direct measurement of the proton beam energy at the marker's position. Fusion-evaporation reactions between the proton beam and marker nucleus result in the emission of delayed characteristic $\gamma$ rays, which are detected off-beam for an improved signal-to-noise ratio. In order to determine the viability of this technique and to establish an experimental setup for future work, the Monte Carlo package GEANT4 was used in combination with ROOT to simulate a treatment scenario with the new method outlined in this work. These simulations show that analyzing the intensity of delayed $\gamma$ rays produced from competing reactions yields a precise measurement of the range of the proton beam relative to the marker, with sub-millimeter uncertainty.